We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for ChAdOx1-S [recombinant] (AstraZeneca Pty Ltd)
Active ingredients
ChAdOx1-S [recombinant]
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Indication
For the prevention of COVID-19
Therapeutic area
Infectious diseases